Host: |
Rabbit |
Applications: |
WB/IF/ICC/ELISA |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Clonality: |
Monoclonal |
Clone ID: |
S0MR |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 0.05% BSA, 50% Glycerol, pH 7.3. |
Purification: |
Affinity purification |
Concentration: |
Lot specific |
Dilution Range: |
WB:1:1000-1:6000IF/ICC:1:100-1:400ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
OSM |
Gene ID: |
5008 |
Uniprot ID: |
ONCM_HUMAN |
Immunogen Region: |
1-100 |
Specificity: |
A synthetic peptide corresponding to a sequence within amino acids 1-100 of human Oncostatin M (P13725). |
Immunogen Sequence: |
MGVLLTQRTLLSLVLALLFP SMASMAAIGSCSKEYRVLLG QLQKQTDLMQDTSRLLDPYI RIQGLDVPKLREHCRERPGA FPSEETLRGLGRRGFLQTLN |
Post Translational Modifications | Propeptide processing is not important for receptor binding activity but may be important growth-inhibitory activity. |
Function | Growth regulator. Inhibits the proliferation of a number of tumor cell lines. Stimulates proliferation of AIDS-KS cells. It regulates cytokine production, including IL-6, G-CSF and GM-CSF from endothelial cells. Uses both type I OSM receptor (heterodimers composed of LIFR and IL6ST) and type II OSM receptor (heterodimers composed of OSMR and IL6ST). Involved in the maturation of fetal hepatocytes, thereby promoting liver development and regeneration. |
Protein Name | Oncostatin-MOsm |
Database Links | Reactome: R-HSA-6785807Reactome: R-HSA-6788467 |
Cellular Localisation | Secreted |
Alternative Antibody Names | Anti-Oncostatin-M antibodyAnti-Osm antibodyAnti-OSM antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance